BRKRBRUKER CORPvs its industry peers
A metric-by-metric comparison of BRUKER CORP against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRKR본 종목 | $9.7B#6 | — | 4.0x#1 | 2.8x#1 | 2.1%#4 | -107.3%#6 | 2.0%#4 | -0.3%#4 | 0.0%#4 | 5#1 | 109.2%#1 | 0.2%#3 |
| VRTX | $133.4B#3 | 30.7x#2 | 6.6x#2 | 11.1x#4 | 8.9%#2 | 838.1%#2 | 34.8%#1 | 19.5%#3 | 25.0%#2 | — | — | — |
| AMGN | $224.2B#1 | 25.8x#1 | 19.2x#6 | 6.1x#2 | 10.0%#1 | 88.5%#3 | 24.7%#3 | 66.0%#2 | 15.1%#3 | — | 56.3%#2 | 2.3%#1 |
| GILD | $187.1B#2 | — | 15.8x#4 | 6.4x#3 | 2.4%#3 | 1672.9%#1 | 34.0%#2 | 71.9%#1 | 26.7%#1 | — | 38.8%#3 | 2.1%#2 |
| RVMD | $43.9B#5 | — | 16.9x#5 | — | — | -88.5%#5 | — | -43.4%#6 | — | — | — | — |
| MRNA | $79.4B#4 | — | 11.7x#3 | 40.8x#5 | -39.9%#5 | 20.8%#4 | -158.1%#5 | -41.7%#5 | -54.6%#5 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-27.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice